Yüklüyor......
The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia
Deferiprone (L1) was originally designed, synthesised and screened in vitro and in vivo in 1981 by Kontoghiorghes G. J. following his discovery of the novel alpha-ketohydroxypyridine class of iron chelators (1978–1981), which were intended for clinical use. The journey through the years for the trea...
Kaydedildi:
| Yayımlandı: | Mediterr J Hematol Infect Dis |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Università Cattolica del Sacro Cuore
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6951358/ https://ncbi.nlm.nih.gov/pubmed/31934321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2020.011 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|